CVS Caremark Given New $87.00 Price Target at Barclays (CVS)
Investment analysts at Barclays raised their price target on shares of CVS Caremark (NYSE:CVS) from $85.00 to $87.00 in a note issued to investors on Wednesday. Barclays’ target price would indicate a potential upside of 12.94% from the company’s current price.
A number of other analysts have also recently weighed in on CVS. Analysts at Leerink Swann raised their price target on shares of CVS Caremark from $85.00 to $87.00 in a research note on Wednesday. Separately, analysts at Argus raised their price target on shares of CVS Caremark from $83.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of CVS Caremark from $76.00 to $86.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. CVS Caremark currently has a consensus rating of “Buy” and an average price target of $80.48.
Shares of CVS Caremark (NYSE:CVS) traded down 0.31% on Wednesday, hitting $77.03. 11,306,321 shares of the company’s stock traded hands. CVS Caremark has a 1-year low of $56.32 and a 1-year high of $79.43. The stock has a 50-day moving average of $76.91 and a 200-day moving average of $74.23. The company has a market cap of $90.356 billion and a price-to-earnings ratio of 19.68. CVS Caremark also was the target of unusually large options trading activity on Monday. Stock traders purchased 7,359 put options on the company. This is an increase of approximately 776% compared to the average daily volume of 840 put options.
CVS Caremark (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.13 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the prior year, the company posted $0.97 earnings per share. The company’s quarterly revenue was up 10.7% on a year-over-year basis. On average, analysts predict that CVS Caremark will post $4.47 earnings per share for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Receive News & Ratings for CVS Caremark Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Caremark Co and related companies with Analyst Ratings Network's FREE daily email newsletter.